Search results
Results from the WOW.Com Content Network
Pancreatitis is a condition characterized by inflammation of the pancreas. [1] The pancreas is a large organ behind the stomach that produces digestive enzymes and a number of hormones. [1] There are two main types, acute pancreatitis and chronic pancreatitis. [1] Signs and symptoms of pancreatitis include pain in the upper abdomen, nausea, and ...
Chronic pancreatitis is a long-standing inflammation of the pancreas that alters the organ's normal structure and functions. [1] It can present as episodes of acute inflammation in a previously injured pancreas , or as chronic damage with persistent pain or malabsorption .
Acute pancreatitis (AP) is a sudden inflammation of the pancreas.Causes include a gallstone impacted in the common bile duct or the pancreatic duct, heavy alcohol use, systemic disease, trauma, elevated calcium levels, hypertriglyceridemia (with triglycerides usually being very elevated, over 1000 mg/dL), certain medications, hereditary causes and, in children, mumps.
The pancreas is involved in digestion and managing blood sugar. When it's is in trouble, diabetes, pancreatitis, or pancreatic cancer can result. How to care for this organ.
Exocrine pancreatic insufficiency (EPI) is the inability to properly digest food due to a lack or reduction of digestive enzymes made by the pancreas.EPI can occur in humans and is prevalent in many conditions [1] such as cystic fibrosis, [2] Shwachman–Diamond syndrome, [3] different types of pancreatitis, [4] multiple types of diabetes mellitus (Type 1 and Type 2 diabetes), [5] advanced ...
Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy can cause relatively minor side effects like nausea and diarrhea. But new research confirms that more serious ...
Necrotising pancreatitis is a “serious development,” the Cleveland Clinic says, as it occurs when part of the pancreas dies. It occurs in 20% cases of pancreatitis — an inflammation of the ...
The FOLFIRINOX chemotherapy regimen using four drugs was found more effective than gemcitabine, but with substantial side effects, thus only suitable for people with good performance status. This is also true of protein-bound paclitaxel (nab-paclitaxel), which was licensed by the FDA in 2013 for use with gemcitabine in pancreas cancer. [ 91 ]